K-numberK251062
Device nameGeistlich Bio-Gide; Geistlich Bio-Gide® Shape; Geistlich Bio-Gide® Compressed; Geistlich Bio-Gide® Forte; Geistlich Bio-Gide® Perio; Geistlich Combi-Kit Collagen®; Geistlich Perio-System Combi Pack
ApplicantGeistlich Pharma AG
Product codeNPL
Device classClass II
Decision dateAug 14, 2025
DecisionSubstantially Equivalent
Regulation872.3930
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Geistlich Bio-Gide® is a family of resorbable bilayer collagen membranes intended for guided tissue and bone regeneration in dental and periodontal applications, including implant augmentation, ridge reconstruction, and filling of bone defects. The membranes have a porous bone-facing surface to allow bone cell ingrowth and a dense tissue-facing surface to prevent fibrous tissue infiltration.

Technological characteristics

All devices in the family are made of porcine collagen without cross-linking and are gamma-sterilized. They are supplied in various pre-cut sizes (ranging from 13×25 mm to 40×50 mm) as single-use devices. Some variants (Shape, Compressed, Forte, Perio) offer modified handling properties or pre-shaped forms; Perio includes cutting templates. Kit versions (Combi-Kit Collagen, Perio-System Combi-Pack) combine the membrane with Geistlich Bio-Oss Collagen® bone graft material in convenience packaging.

Test standards cited

ISO 10993-1:2018 (biocompatibility), ISO 11137-1:2006, ISO 11137-2:2013, ISO 11137-3:2017 (sterilization), ISO 11607-1/-2 (packaging), ISO 22442-3:2007 (viral safety), ASTM F2450-18 (porosity), ASTM F2150-19 (tensile strength), ASTM F2212-20 (thermal analysis, collagen degradation, molecular weight distribution).

Substantial equivalence argument

Each device variant claims substantial equivalence to an appropriate predicate device (primarily K212463, with K171643 referenced) based on identical material composition (porcine collagen), identical sterilization method (gamma irradiation), identical or similar sizes, and identical indications for use. The submission addresses a new slaughterhouse for existing animal-source suppliers and non-significant manufacturing facility and equipment changes through comparative physical and biochemical testing (SEM, porosity, tensile strength, DSC, suture pull-out, solubility, enzymatic degradation, SDS-PAGE, hydration) plus leveraged biocompatibility, sterilization, shelf-life, and clinical data from predicate devices, demonstrating equivalent performance.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →